The impressive progress made by the Indian pharmaceutical industry in terms of infrastructure development, technology base creation and manufacturing a wide range of products shows its competitiveness. The industry now produces bulk drugs belonging to all major therapeutic groups. Strong scientific and technical manpower, and pioneering work done in process development have contributed to this. The growth rate has been around 15% for bulk drugs and 20% for formulations during the 1990s. The performance on the export front is also noteworthy, clocking a growth rate of more than 28% in 2002-03. Nevertheless, the scope to increase the volume of exports is tremendous. The future of this industry seems to be heading in the right direction.

The saga of the competitive Indian pharma industry and strategic portends for the future

Indian Pharmaceutical industry with its excellent manufacturing facilities, infrastructure and competitiveness will continue to do very well in the future, reveals an exclusive research conducted recently on sunrise sectors in India. There has been a lot of expectancy that has been prevalent about the state of the industry after 2005. Research has corroborated these notions and suggested directions for Indian Pharma industry to do well globally.

Indian pharma market, strategic outsourcing destination, impressive progress, Indian pharmaceutical industry, infrastructure development, technology, manufacturing, products, competitiveness, drugs, therapeutic groups, scientific, technical manpower, process development, formulations, export, industry.